Originalbeitrag in Fachzeitschrift
Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
Porpaczy E, Tripolt S, Hoelbl-Kovacic A, Gisslinger B, Bago-Horvath Z, Casanova-Hevia E, et al. Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy. Blood. 2018;132(7):694-706. doi:https://doi.org/10.1182/blood-2017-10-810739
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Thomas Kolbe
ao.Univ.Prof. Dipl.-Ing.Dr. Thomas Kolbe
